<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><!-- InstanceBegin template="/Templates/ContentPage_Standard.dwt" codeOutsideHTMLIsLocked="false" -->

<head>
<!-- InstanceParam name="content" type="boolean" value="true" --><!-- InstanceParam name="id" type="text" value="undefined" --><!-- InstanceParam name="class" type="text" value="secondTier" --><!-- InstanceParam name="OptionalLocalSearch" type="boolean" value="false" --><!-- InstanceParam name="OptionalLocalA-Z" type="boolean" value="false" -->
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<!-- InstanceBeginEditable name="meta-data" -->
<meta name="Keywords" 		content="" />
<meta name="DC.Subject" 	content="" />
<meta name="DC.Language" 	scheme="ISO 639-2" content="eng" />
<!-- InstanceEndEditable -->
<meta name="template.version" content="2.2.0" />
<!-- @package: TemplatePackage 'B' @version: "2.2.0" -->
<!-- InstanceBeginEditable name="title-tag" -->
<title>CDC - 2009 CAUTI Guideline:VIII Evidence Review - HICPAC</title>
<!-- InstanceEndEditable -->
<style type="text/css" media="tv">
empty{color:#000};@import "../../TemplatePackage/css/B/wysiwyg/wysiBaseHome.css"/**/;
</style>
<style type="text/css" media="screen, projection">
@import "../../TemplatePackage/css/B/base-float.css"/**/;
</style>
<script type="text/javascript" src="../../TemplatePackage/js/B/jquery.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/jquery.watermark.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/common.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/startup.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/blocks-ie.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/video.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/navScripts.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/share.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/govdelivery.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/external.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/plugins.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/syndicateThisPage.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/css-include.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/socialMedia.js"></script>

<!-- compliance patch for microsoft browsers -->
<!--[if IE 6]>
<script type="text/javascript" src="/TemplatePackage/js/B/pngfix.js"></script>
<script type="text/javascript" src="/TemplatePackage/js/B/blocks-ie6.js"></script>
<![endif]-->

<!--[if IE 7]>
<link rel="stylesheet" type="text/css" href="/TemplatePackage/css/B/ie7_fixes.css" />
<![endif]-->

<!--[if IE 8]>
<link rel="stylesheet" type="text/css" href="/TemplatePackage/css/B/ie8_fixes.css" />
<![endif]-->

<!--[if lte IE 8]>
<script type="text/javascript" src="/TemplatePackage/js/B/jquery.curvycorners.js"></script>
<![endif]-->
<style type="text/css" media="print">@import "../../TemplatePackage/css/B/print.css";</style>

<link rel="shortcut icon" href="../../TemplatePackage/images/home/favicon.ico" />
<link rel="home" href="../../index.html" title="Home" />

<!-- Begin Survey scripts -->
<script type="text/javascript" src="../../JScript/foresee/foresee-trigger.js"></script>
<script type="text/javascript" src="../../JScript/foresee-variables.js"></script>
<!-- End Survey scripts -->


<!-- Local Topic Styles -->
<!-- InstanceBeginEditable name="local-css" -->
<style type="text/css" media="all">
@import "../local/B/css/local.css"/**/;
</style>
<!--[if IE]>
<script defer language="javascript" type="text/javascript">
		var cdcLeftNav = new CDC.LeftNav("nav-primary");
		cdcLeftNav.render();
</script>
<![endif]-->
<!--[if ! IE]><!-->
<script language="javascript" type="text/javascript">
$().ready(function(){
		
		var cdcLeftNav = new CDC.LeftNav("nav-primary", location.pathname, true, true);
		cdcLeftNav.render();

});
</script>
<!--<![endif]-->

<!-- InstanceEndEditable -->
</head>

<body id="undefined" class="secondTier">

<div id="skipmenu">
	<a href="008_evidenceReview.html#searchBox" class="skippy" title="Skip to search">Skip directly to search</a>
	<a href="008_evidenceReview.html#az" class="skippy" title="Skip to A to Z list">Skip directly to A to Z list</a>
	<a href="008_evidenceReview.html#nav" class="skippy" title="Skip to navigation">Skip directly to navigation</a>
	<a href="008_evidenceReview.html#content-main" class="skippy" title="Skip to content">Skip directly to site content</a>
	<a href="008_evidenceReview.html#content-secondary" class="skippy" title="Skip to page options">Skip directly to page options</a>
</div>
<div id="wrapper">
	<div class="top"></div>
	<div id="branding">
		<span id="homeward"><a href="../../index.html" title="Return to the CDC Home Page">CDC Home</a></span>
<div id="branding-logo">
	<div id="branding-logoImage"><img src="../../TemplatePackage/images/cdcHeaderLogo.gif" width="470" height="47" alt="CDC 24/7: Saving Lives. Protecting People.&trade;" border="0" /><a href="../../index.html" title="CDC 24/7: Saving Lives. Protecting People.&trade;"><span>CDC 24/7: Saving Lives. Protecting People.&trade;</span></a></div>
	<div id="searchForm" class="searchResize"><a name="search"></a>
		<form id="searchCDC" method="get" action="https://search.cdc.gov/search">
			<fieldset>
				<div id="cdc-Query">
					<label for="searchBox" class="overlabel search">Search The CDC</label>
					<input id="searchBox" class="searchBox" name="query" maxlength="256" type="text" />
				</div>
				<div id="cdc-Submit">
					<!-- label for="searchButton" class="searchButton">Search Button</label -->
					<input id="searchButton" class="searchButton" src="../../TemplatePackage/images/home/search_button.gif" name="searchButton" alt="Search" type="image" />
					<input name="action" value="search" type="hidden" />
				</div>
				<input type="hidden" name="utf8" value="&#x2713;"/>
				<input type="hidden" name="affiliate" value="cdc-main"/>
			</fieldset>
		</form>
	</div>
</div>
<noscript>
<div class="noscript"> Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: <a href="../../Other/about_cdcgov.html" title="Browser requirements for CDC.gov">About CDC.gov</a>.</div>
</noscript>
<!--<div id="emergency-alert">
<h1></h1> 
<p></p>
<a href="#"></a>
</div>-->
		<div id="topic-title"><!-- InstanceBeginEditable name="topic-title" -->
			<h2><a href="../index.html">Healthcare Infection Control Practices Advisory Committee (HICPAC)</a></h2>
			<!-- InstanceEndEditable -->
		</div>
	</div>
	
	<div id="content">
		<div id="content-inner">
			<!-- ########## LEFT NAVIGATION STARTS HERE ########## -->
			<div id="nav-container"><!-- InstanceBeginEditable name="left-nav-include" -->
				<div id="nav">
  <h3><a href="../index.html">HICPAC</a></h3>
	<ul id="nav-primary">
    <li><a href="../about.html">About HICPAC</a></li>
    <li><a href="../roster.html">Member Roster</a></li>
    <li><a href="../charter.html">Charter</a> </li>
    <li><a href="../eCalendar.html">Event Calendar</a>
      <!--ul>
        <li><a href="/hicpac/agenda.html">Meeting Agenda</a></li>  
      </ul-->
    </li>
    <li><a href="../guidelineMethod/guidelineMethod.html">Methodology Guideline</a>
      <ul>
        <li><a href="../guidelineMethod/001_methods_background.html">Background</a></li>
        <li><a href="../guidelineMethod/002_methods_emergingNeeds.html">Strengthening HICPAC Guidelines to Address Emerging Needs</a></li>
        <li><a href="../guidelineMethod/003_methods_Organiz2AccomplishGoals.html">Organizing to Accomplish Our Goals</a> </li>
        <li><a href="../guidelineMethod/004_methods_guidelineDevelopment.html">Methods in Guideline Development</a></li>
        <li><a href="../guidelineMethod/005_methods_challengesOpportunities.html">Looking to Future Challenges and Opportunities</a></li>
        <li><a href="../guidelineMethod/007_methods_References.html">References</a></li>
        <li><a href="../guidelineMethod/008_methods_tables.html">Tables</a></li>
        <li><a href="../guidelineMethod/011_methods_figures.html">Figures</a></li>
      </ul>
    </li>
	<!--li><a href="/hicpac/projects_in_progress.html">Projects in Progress</a></li-->
	<li><a href="../pubs.html">Publications</a>
			<ul>
			  <li><a href="../BSI/BSI-guidelines-2011.html">2011 Guidelines for the Prevention of Intravascular Catheter-Related Infections</a>
		        <ul>
		          <li><a href="../BSI/toc-BSI-guidelines-2011.html">Table of Contents</a></li>
		          <li><a href="../BSI/01-BSI-guidelines-2011.html">Notice to Readers</a> </li>
		          <li><a href="../BSI/02-bsi-summary-of-recommendations-2011.html">Summary Of Recommendations</a> </li>
		          <li><a href="../BSI/03-bsi-summary-of-recommendations-2011.html">Patient Cleansing 
		            </a></li>
		          <li><a href="../BSI/04-bsi-background-info-2011.html">Background Information</a></li>
		          <li><a href="../BSI/05-bsi-background-info-2011.html">Maximal Sterile Barrier Precautions 
		            </a></li>
		          <li><a href="../BSI/06-bsi-background-info-2011.html">Antibiotic Lock Prophylaxis, Antimicrobial Catheter Flush and Catheter Lock Prophylaxis 
		            </a></li>
		          <li><a href="../BSI/07-bsi-background-info-2011.htmles-2011.html">Replacement of Administration Sets</a></li>
		          <li><a href="../BSI/bsi-table-1-2011.html">Table 1. Catheters used for venous and arterial access</a></li>
		          <li><a href="../BSI/13-references-BSI-guidelines-2011.html">References</a></li>
		          <li><a href="../BSI/11-appendix-B-BSI-guidelines-2011.html">Appendix B. Disclosure of financial interests or relationships</a></li>
		          <li><a href="../BSI/12-appendix-C-BSI-guidelines-2011.html">Appendix C. Summary of Recommendations</a></li>
	            </ul>
			  </li>
		      <li><a href="../norovirus/002_norovirus-toc.html">2011 Norovirus Guidelines
		        </a>
		        <ul>
		          <li><a href="../norovirus/003_norovirus-abbreviations.html">Abbreviations</a></li>
					   
					   <li><a href="../norovirus/001_norovirus.html">Acknowledgement</a></li>
					   <li><a href="../norovirus/004_norovirus-exec-summary.html">Executive Summary</a></li>
					   <li><a href="../norovirus/005_norovirus-summaryOrecs.html">Summary of Recommendations</a></li>
					   <li><a href="../norovirus/006_norovirus-implement-audit.html">Implementation and Audit</a> </li>
					   <li> <a href="../norovirus/007_norovirus-recs-further-research.html">Recommendations for Further Research					     </a></li>
					   <li><a href="../norovirus/008_norovirus-background.html">Background					     </a></li>
					   <li><a href="../norovirus/009_norovirus-scope.html">Scope and Purpose</a> </li>
					   <li><a href="../norovirus/010_norovirus-methods.html">Methods</a> </li>
					   <li><a href="../norovirus/011_norovirus-evidence-review.html">Evidence Review Question 1</a>				       </li>
                       <li><a href="../norovirus/012_norovirus-evidence-q2.html">Question 2</a></li>
                       <li><a href="../norovirus/013_norovirus-evidence-q3.html">Question 3</a></li>
                  <li><a href="../norovirus/norovirus-appendix-1.html">Appendix 1</a></li>
                       <li><a href="../norovirus/norovirus-appendix-1b.html">Appendix 1B</a> </li>
                       <li><a href="../norovirus/tables/evidence-Table1.html">Evidence, Grade &amp; Study Quality Assessment Tables</a></li>
                  <li><a href="../norovirus/norovirus-appendix-3.html">Appendix 3</a></li>
                       <li><a href="../norovirus/norovirus-appendix-4.html">Appendix 4</a></li>
                       <li><a href="../norovirus/norovirus-references.html">References</a></li>
		        </ul>
		      </li>
	          <li><a href="../Disinfection_Sterilization/acknowledg.html">2008 Disinfection &amp; Sterilization Guideline</a>               
	            <ul>
	              <li><a href="../Disinfection_Sterilization/toc.html">Table of Contents</a></li>
	              <li><a href="../Disinfection_Sterilization/1_sumIntroMethTerms.html">Executive Summary</a> </li>
	              <li><a href="../Disinfection_Sterilization/2_approach.html">Approach to Disinfection and Sterilization</a> 
	                  <ul>
	                    <li><a href="../Disinfection_Sterilization/3_0disinfectEquipment.html">Disinfection of Healthcare Equipment</a></li>
                        <li><a href="../Disinfection_Sterilization/3_1deLaparoArthro.html">Laparoscopes and Arthroscopes</a> </li>
                        <li><a href="../Disinfection_Sterilization/3_2contaminatedDevices.html">Disinfection of HBV, HCV, HIV or TB-Contaminated Devices</a></li>
                        <li><a href="../Disinfection_Sterilization/3_3inactivBioAgents.html">Inactivation of Bioterrorist Agents</a></li>
                        <li><a href="../Disinfection_Sterilization/3_4surfaceDisinfection.html">Surface Disinfection</a></li>
                    </ul>
	              </li>
                  <li><a href="../Disinfection_Sterilization/4_0efficacyDS.html">Factors Affecting The Efficacy Of Disinfection And Sterilization</a></li>
                  <li><a href="../Disinfection_Sterilization/5_0cleaning.html">Cleaning</a></li>
                  <li><a href="../Disinfection_Sterilization/6_0disinfection.html">Disinfection</a>
                    <ul>
                      <li><a href="../Disinfection_Sterilization/7_0formaldehyde.html">Formaldehyde</a></li>
                      <li><a href="../Disinfection_Sterilization/8_0Iodophors.html">Iodophors</a></li>
                      <li><a href="../Disinfection_Sterilization/9_0PceticAcidHydroPoxide.html">Peracetic Acid and Hydrogen Peroxide</a></li>
                    </ul>
                  </li>
                  <li><a href="../Disinfection_Sterilization/10_0MiscAgents.html">Miscellaneous Inactivating Agents</a></li>
                  <li><a href="../Disinfection_Sterilization/11_0regulatory_Framework.html">Regulatory Framework for Disinfectants and Sterilants</a></li>
                  <li><a href="../Disinfection_Sterilization/13_0Sterilization.html">Sterilization</a>
                      <ul>
	                      
                        <li><a href="../Disinfection_Sterilization/13_02sterilization.html">Low-Temperature Sterilization Technologies</a></li>
		                          
                        <li><a href="../Disinfection_Sterilization/13_06PeraceticAcidSterilization.html">Peracetic Acid Sterilization</a></li>
		                         
                        <li><a href="../Disinfection_Sterilization/13_10otherSterilizationMethods.html">Other Sterilization Methods</a></li>
                        <li><a href="../Disinfection_Sterilization/13_11sterilizingPractices.html">Sterilizing Practices</a></li>
                    </ul>
                  </li>
                  <li><a href="../Disinfection_Sterilization/14_00ReuseMedicalDevices.html">Reuse of Single-Use Medical Devices</a></li>
                  <li><a href="../Disinfection_Sterilization/17_00Recommendations.html">Recommendations for Disinfection and Sterilization in Health-Care Facilities</a></li>
                  <li><a href="../Disinfection_Sterilization/18_00PerformanceIndicators.html">Performance Indicators</a></li>
                  <li><a href="../Disinfection_Sterilization/19_00glossary.html">Glossary</a></li>
                  <li><a href="../Disinfection_Sterilization/table_1.html">Tables &amp; Figure</a>
                    <ul>
                      <li><a href="../Disinfection_Sterilization/table_2.html">Table 2, 3</a></li>
                      <li><a href="../Disinfection_Sterilization/fig_1.html">Figure 1</a></li>
                      <li><a href="../Disinfection_Sterilization/table_4.html">Table 4</a></li>
                      <li><a href="../Disinfection_Sterilization/table_5.html">Table 5</a></li>
                      <li><a href="../Disinfection_Sterilization/table_6.html">Table 6</a></li>
                      <li><a href="../Disinfection_Sterilization/table_7.html">Table 7, 8, 9</a></li>
                      <li><a href="../Disinfection_Sterilization/table_10.html">Table 10, 11, 12</a></li>
                    </ul>
                  </li>
                  <li><a href="../Disinfection_Sterilization/20_00reference.html">References</a></li>
                </ul>
              </li>
	          <li><a href="../2007IP/2007isolationPrecautions.html">Guideline for Isolation Precautions 2007</a>
				  <ul>
                        <li><a href="../2007IP/2007ip_ExecSummary.html">Executive Summary</a></li>
                        <li> <a href="../2007IP/2007ip_part1.html">Part I: Review of Scientific Data Regarding Transmission of Infectious Agents in Healthcare Settings</a></li>
                        <li><a href="../2007IP/2007ip_part2.html">Part II: Fundamental elements needed to prevent transmission of infectious agents in healthcare settings</a></li>
                        <li><a href="../2007IP/2007ip_part3.html">Part III: Precautions to Prevent Transmission of Infectious Agents</a></li>
                        <li><a href="../2007IP/2007ip_part4.html">Part IV: Recommendations</a></li>
                        <li><a href="../2007IP/2007ip_appendA.html">Appendix A</a></li>
                        <li><a href="../2007IP/2007ip_tables.html">Tables 1 - 5</a>
                          <ul>
                            <li><a href="../2007IP/2007ip_table2.html">Table 2</a></li>
                            <li><a href="../2007IP/2007ip_table3.html">Table 3</a></li>
                            <li><a href="../2007IP/2007ip_table4.html">Table 4</a></li>
                            <li><a href="../2007IP/2007ip_table5.html">Table 5</a></li>
                          </ul>
                        </li>
                        <li><a href="../2007IP/2007ip_fig.html">Figure. Example of Safe Donning and Removal of PPE</a></li>
                        <li><a href="../2007IP/2007ip_glossary.html">Glossary</a></li>
                        <li><a href="../2007IP/2007ip_reference.html">References</a></li>
                </ul>
			  </li>
			    
	            <li><a href="001_cauti.html">2009 CAUTI Guideline</a>
	              <ul>
	                <li><a href="002_cauti_toc.html">Table of Contents</a>
	                  <!--<ul><li><a href="/hicpac/Disinfection_Sterilization/1_sumIntroMethTerms-levi.html">test</a></li></ul>-->
                    </li>
                      <li><a href="02_cauti2009_abbrev.html">Abbreviations</a></li>
                      <li><a href="003_cauti2009_execSum.html">I. Executive Summary</a></li>
                      <li><a href="002_cauti_sumORecom.html">II. Summary of Recommendations</a></li>
                      <li><a href="003_ImplementAudit.html">III. Implementation and Audit</a></li>
                      <li><a href="004_furtherResearch.html">IV. Recommendations for Further Research</a></li>
                      <li><a href="005_background.html">V. Background</a></li>
                      <li><a href="006_scopePurpose.html">VI. Scope and Purpose</a></li>
                      <li><a href="007_methods.html">VII. Methods</a></li>
                      <li><a href="008_evidenceReview.html">VIII. Evidence Review</a></li>
                      <li><a href="009_cauti2009_References.html">References</a></li>
                      <li><a href="010_cauti2009_figs.html">Figures</a></li>
		          </ul>
              </li>
              
              <li><a href="../CAUTI_fastFacts.html">CAUTI Guideline Fast Facts</a></li>
              <li><a href="../uti_saint_video.html">Podcast: Dr. Sanjay Saint discusses CAUTIs</a></li>
              <li><a href="../mdro/mdro_0.html">Management of MDRO's in Healthcare Settings</a>
	          <ul>
	            <li><a href="../mdro/mdro_toc.html">Table of Contents</a></li>
	            <li><a href="../mdro/mdro_1.html">Introduction</a></li>
	            <li><a href="../mdro/mdro_2.html">Background</a></li>
	            <li><a href="../mdro/mdro_3.html">Epidemiology of MDROs</a></li>
	            <li><a href="../mdro/mdro_4.html">MDRO Prevention and Control</a></li>
	            <li><a href="../mdro/mdro_4_1.html">Discussion</a></li>
	            <li><a href="../mdro/mdro_5.html">Prevention of transmission of Multidrug Resistant Organisms </a></li>
	            <li><a href="../mdro/mdro_table1.html">Tables 1-2</a></li>
	            <li><a href="../mdro/mdro_table3.html">Table 3</a> </li>
	            <li><a href="../mdro/mdro_glossary.html">Glossary - Multidrug-Resistant Organisms</a></li>
	            <li><a href="../mdro/mdro_reference.html">References</a></li>
              </ul>
	        </li>
	        <li><a href="../pubReportGuide/publicReportingHAI.html">Guidance on Public Reporting of HAIs 2003</a>
			      <ul>
			        <li><a href="../pubReportGuide/prg_tbl1.html">Table 1</a></li>
		            <li><a href="../pubReportGuide/prg_tbl2.html">Table 2</a></li>
                    <li><a href="../pubReportGuide/prHAI_reference.html">Reference</a></li>
	              </ul>
		      </li>
            <li><a href="../SSI/001_SSI.html">Guideline for Prevention of Surgical Site Infection, 1999 </a>
              <ul>
                <li><a href="../SSI/toc_SSI.html"> Table of contents</a></li>
                
                <li><a href="../SSI/002_SSI.html">Surgical Site Infection (SSI): An Overview</a></li>
                <li><a href="../SSI/003_SSI.html">Microbiology</a></li>
                <li><a href="../SSI/004_SSI.html"> Operative characteristics: Preoperative issues                                 </a></li>
                <li><a href="../SSI/005_SSI.html">Operative characteristics: Intraoperative issues 
                                 </a></li>
                <li><a href="../SSI/006_SSI.html">SSI Surveillance </a></li>
                <li><a href="../SSI/007_SSI.html">Recommendations for Prevention of SSI</a></li>
                <li><a href="../SSI/ref-SSI.html">References </a></li>
                <li><a href="../SSI/figure-SSI.html">Figure</a></li>
                <li><a href="../SSI/table1-SSI.html">Table 1</a></li>
                <li><a href="../SSI/table2-SSI.html">Table 2</a></li>
                <li><a href="../SSI/table3-SSI.html">Table 3</a></li>
                <li><a href="../SSI/table4-SSI.html">Table 4</a></li>
                <li><a href="../SSI/table5-SSI.html">Table 5</a></li>
                <li><a href="../SSI/table6-SSI.html">Table 6</a></li>
                <li><a href="../SSI/table7-8-9-10-SSI.html">Table 7-8-9-10</a></li>
              </ul>
            </li>
            <li><a href="../Pubs/Antibiotic-Stewardship-Statement.html">Antibiotic Stewardship Statement for Antibiotic Guidelines, 2016</a></li>
      </ul>
	  </li>
       
	<li><a href="../presentations.html">Proceedings &amp; Presentations</a>
	  <!--ul>
	    <li><a href="/hicpac/transcript-07-23.html">July 09 - Interim Guidance for Care of Patients with Confirmed /Suspected 2009 H1N1</a></li>
        <li><a href="/hicpac/h1n12009.html">Summary of Recommendations for Care of Patients with Confirmed /Suspected 2009 H1N1</a></li>
	  </ul-->
	</li>
   
    <!--li><a href="/hicpac/registration.html">HICPAC Online Registration</a></li-->
    <li><a href="../contact.html">Contact HICPAC</a></li>
  </ul>
</div>
<div class="bottom"></div>

				
				<!-- InstanceEndEditable -->
			</div>
			
			<!-- ########## BREADCRUMBS START HERE ########## -->
			<!-- InstanceBeginEditable name="breadcrumbs" -->
			<div id="breadBox">
	<ul id="breadcrumbs">
		<li style="display:none;"></li>
	</ul>
</div>
			<!-- InstanceEndEditable -->
			
			<div id="content-main">
				<div class="main-inner">
					<!-- InstanceBeginEditable name="features" --><!-- InstanceEndEditable -->
					<!-- InstanceBeginEditable name="content-main" -->
					 <h1>Guideline for Prevention of Catheter-associated Urinary Tract Infections, 2009</h1>
					
                     <p class="label"><a href="https://www.cdc.gov/hicpac/pdf/CAUTI/CAUTIguideline2009final.pdf" >2009 CAUTI Guidelines </a>(407 KB / 67 pages) and 
                       <a href="https://www.cdc.gov/hicpac/pdf/CAUTI/CAUTI_GuidelineAppendices2009final.pdf"> Appendices</a> (4.41 MB / 268 pages) are available for download in PDF format.                      </p>
                       
   
<div id="onthispage">
<div class="rounders grey bulleted-links">
<div class="inner">
<div class="t"></div>

<h4>On this Page</h4>
<div class="subc">
<ul>
<li><a href="008_evidenceReview.html#1">Q1. Who should receive urinary catheters?</a>
  <ul>
    <li><a href="008_evidenceReview.html#1a">Q1A. When is urinary catheterization necessary?</a></li>
    <li><a href="008_evidenceReview.html#1b">Q1B. What are the risk factors for CAUTI?</a></li>
    <li><a href="008_evidenceReview.html#1c">Q1C. What populations are at highest risk of mortality from urinary catheters?</a></li>
  </ul>
</li>
<li><a href="008_evidenceReview.html#2">Q2. For those who may require urinary catheters, what are the best practices?</a>
  <ul>
    <li><a href="008_evidenceReview.html#2a">Q2A. What are the risks and benefits associated with different approaches to catheterization?</a></li>
    <li><a href="008_evidenceReview.html#2b">Q2B. What are the risks and benefits associated with different catheters or collecting systems?</a></li>
    <li><a href="008_evidenceReview.html#2c">Q2C. What are the risks and benefits associated with different catheter management techniques?</a></li>
    <li><a href="008_evidenceReview.html#2d">Q2D. What are the risks and benefits associated with different systems interventions?</a></li>
  </ul>
</li>
<li><a href="008_evidenceReview.html#3">Q3: What are the best practices for preventing UTI associated with obstructed urinary catheters?</a></li>
</ul>
</div>
</div>

<div class="b">
<div></div>
</div>
</div>
</div>

<h2>VIII. Evidence Review</h2>

 <a name="1" id="1"></a>
<h3>Q1. Who should receive urinary catheters?</h3>
<p>To answer this question, we focused on three subquestions: A) When is urinary catheterization necessary? B) What are the risk factors for CAUTI? and C) What populations are at highest risk of mortality from urinary catheters?</p>

<p class="topOPage"><a href="008_evidenceReview.html#">Top of Page</a></p> 
 <a name="1a" id="1a"></a>
<h4> Q1A. When is urinary catheterization necessary?</h4>
<p>The available data examined five main populations. In all populations, we considered CAUTI outcomes as well as other outcomes we deemed critical to weighing the risks and benefits of catheterization. The evidence for this question consists of 1 systematic review,37 9 RCTs,38-46 and 12 observational studies.47-58 The findings of the evidence review and the grades for all important outcomes are shown in Evidence Review Table 1A.
</p>
<p>  
  For operative patients, low-quality evidence suggested a benefit of avoiding urinary catheterization.37-44,47-49 This was based on a decreased risk of bacteriuria/unspecified UTI, no effect on bladder injury, and increased risk of urinary retention in patients without catheters. Urinary retention in patients without catheters was specifically seen following urogenital surgeries. The most common surgeries studied were urogenital, gynecological, laparoscopic, and orthopedic surgeries. Our search did not reveal data on the impact of catheterization on peri-operative hemodynamic management. 
</p>
<p> 
  For incontinent patients, low-quality evidence suggested a benefit of avoiding urinary catheterization.45,50-52 This was based on a decreased risk of both SUTI and bacteriuria/unspecified UTI in male nursing home residents without urinary catheters compared to those with continuous condom catheters. We found no difference in the risk of UTI between having a condom catheter only at night and having no catheter. Our search did not reveal data on the impact of catheterization on skin breakdown. 
</p>
<p> 
  For patients with bladder outlet obstruction, very low-quality evidence suggested a benefit of a urethral stent over an indwelling catheter.53 This was based on a reduced risk of bacteriuria in those receiving a urethral stent. Our search did not reveal data on the impact of catheterization versus stent placement on urinary complications.
</p>
<p> 
  For patients with spinal cord injury, very low-quality evidence suggested a benefit of avoiding indwelling urinary catheters.54,56 This was based on a decreased risk of SUTI and bacteriuria in those without indwelling catheters (including patients managed with spontaneous voiding, clean intermittent catheterization [CIC], and external striated sphincterotomy with condom catheter drainage), as well as a lower risk of urinary complications, including hematuria, stones, and urethral injury (fistula, erosion, stricture). 
</p>
<p> 
  For children with myelomeningocele and neurogenic bladder, very low-quality evidence suggested a benefit of CIC compared to urinary diversion or self voiding.46,57,58 This was based on a decreased risk of bacteriuria/unspecified UTI in patients receiving CIC compared to urinary diversion, and a lower risk of urinary tract deterioration (defined by febrile urinary tract infection, vesicoureteral reflux, hydronephrosis, or increases in BUN or serum creatinine) compared to self-voiding and in those receiving CIC early (< 1 year of age) versus late (> 3 years of age). 
  
</p>
<div class="margin">
<div class="module rounders">
<div class="inner">
<div class="t"></div>

<h3>Evidence Review Table 1A. When is urinary catheterization necessary?</h3>

<div class="subColumns">
<div class="subc">
<p> 1A.1. Use urinary catheters in operative patients only as necessary, rather than routinely.<strong> (Category IB)</strong></p>
<p>1A.2. Avoid use of urinary catheters in patients and nursing home residents for management of incontinence. <strong>(Category IB) </strong></p>
<p>1A.2.a. Further research is needed on periodic (e.g., nighttime) use of external catheters in incontinent patients or residents and the use of catheters to prevent skin breakdown. <strong>(No recommendation/unresolved issue)  </strong></p>
<p>1A.3. Further research is needed on the benefit of using a urethral stent as an alternative to an indwelling catheter in selected patients with bladder outlet obstruction. <strong>(No recommendation/unresolved issue)</strong> </p>
<p>1A.4. Consider alternatives to chronic indwelling catheters, such as intermittent catheterization, in spinal cord injury patients. <strong>(Category II)  </strong></p>
<p>1A.5. Consider intermittent catheterization in children with myelomeningocele and neurogenic bladder to reduce the risk of urinary tract deterioration. <strong>(Category II)</strong></p>
</div>
</div>
</div>

<div class="b">
<div></div>
</div>
</div>
</div>
 <p class="topOPage"><a href="008_evidenceReview.html#">Top of Page</a></p> 
 <a name="1b" id="1b"></a>
<h4>Q1B. What are the risk factors for CAUTI?</h4>
<p>To answer this question, we reviewed the quality of evidence for those risk factors examined in more than one study. We considered the critical outcomes for decision-making to be SUTI and bacteriuria. The evidence for this question consists of 11 RCTs59-69 and 37 observational studies.9,50,54,70-103 The findings of the evidence review and the grades for all important outcomes are shown in Evidence Review Table 1B.  </p>

<p>For SUTI, 50,54,61,62,74,75,79,83,102,103 low-quality evidence suggested that female sex, older age, prolonged catheterization, impaired immunity, and lack of antimicrobial exposure are risk factors.  Very low quality evidence suggested that catheter blockage and low albumin level are also risk factors.  For bacteriuria, 9,59-61,63-68,72,73,76-78,82,84-86,89-94,96-100 multiple risk factors were identified; there was high quality evidence for prolonged catheterization and moderate quality evidence for female sex, positive meatal cultures, and lack of antimicrobial exposure.  Low-quality evidence also implicated the following risk factors for bacteriuria: older age, disconnection of the drainage system, diabetes, renal dysfunction, higher severity of illness, impaired immunity, placement of the catheter outside of the operating room, lower professional training of the person inserting the catheter, incontinence, and being on an orthopaedic or neurology service.  Our search did not reveal data on adverse events and antimicrobial resistance associated with antimicrobial use, although one observational study found that the protective effect of antimicrobials lasted only for the first four days of catheterization, and that antimicrobial exposure led to changes in the epidemiology of bacterial flora in the urine.</p>
<div class="margin">
<div class="module rounders">
<div class="inner">
<div class="t"></div>

<h3>Evidence Review Table 1B.  What are the risk factors for CAUTI?</h3>

<div class="subColumns">
<div class="subc">
<p> 1B.1. Following aseptic insertion of the urinary catheter, maintain a closed drainage system. (Category IB)a
</p>
<p>
1B.2. Insert catheters only for appropriate indications, and leave in place only as long as needed. (Category IB)b
</p>
<p>
1B.3. Minimize urinary catheter use and duration of use in all patients, particularly those at higher risk for CAUTI such as women, the elderly, and patients with impaired immunity. (Category IB)
</p>
<p>
1B.4. Ensure that only properly trained persons (e.g., hospital personnel, family members, or patients themselves) who know the correct technique of aseptic catheter insertion and maintenance are given this responsibility. (Category IB)
</p>
<p>
1B.5. Maintain unobstructed urine flow. (Category IB)c
</p>
</div>
</div>
</div>

<div class="b">
<div></div>
</div>
</div>
<p>a More data are available under Question 2B.
  <br />
  b More data are available under Question 2C.
  <br />
c More data are available under Question 2D.</p>
</div>


<p class="topOPage"><a href="008_evidenceReview.html#">Top of Page</a></p> 
 <a name="1c" id="1c"></a>
 
<h4>Q1C. What populations are at highest risk of mortality from urinary catheters?</h4>
<p>To answer this question, we reviewed the quality of evidence for those risk factors examined in more than one study. The evidence for this question consists of 2 observational studies.7,74 The findings of the evidence review and the grades for all important outcomes are shown in Evidence Review Table 1C.  </p>
<p>Low-quality evidence suggested that older age, higher severity of illness, and being on an internal medicine service compared to a surgical service were independent risk factors for mortality in patients with indwelling urinary catheters. Both studies evaluating these risk factors found the highest risk of mortality in patients over 70 years of age. Low-quality evidence also suggested that CAUTI was a risk factor for mortality in patients with catheters. </p>
<div class="margin">
<div class="module rounders">
<div class="inner">
<div class="t"></div>

<h3>Evidence Review Table 1C.  What populations are at highest risk of mortality from catheters?</h3>

<div class="subColumns">
<div class="subc">
<p> 1C.1. Minimize urinary catheter use and duration in all patients, particularly those who may be at higher risk for mortality due to catheterization, such as the elderly and patients with severe illness. (Category IB)</p>

</div>
</div>
</div>

<div class="b">
<div></div>
</div>
</div>
</div>

<p class="topOPage"><a href="008_evidenceReview.html#">Top of Page</a></p> 
 <a name="2" id="2"></a>
 
<h3>Q2. For those who may require urinary catheters, what are the best practices?</h3>
<p>
To answer this question, we focused on four subquestions: A) What are the risks and benefits associated with different approaches to catheterization?, B) What are the risks and benefits associated with different types of catheters or collecting systems?, C) What are the risks and benefits associated with different catheter management techniques, and D) What are the risks and benefits associated with different systems interventions?
</p>

<p class="topOPage"><a href="008_evidenceReview.html#">Top of Page</a></p> 
 <a name="2a" id="2a"></a>
<h4>
  Q2A. What are the risks and benefits associated with different approaches to catheterization?</h4>
<p>
The available data examined the following comparisons of different catheterization approaches:
</p>
<ol>
  <li>
     External versus indwelling urethral  </li>
  <li> Intermittent versus indwelling urethral    </li>
  <li>Intermittent versus suprapubic    </li>
  <li> Suprapubic versus indwelling urethral    </li>
  <li>Clean intermittent versus sterile intermittent </li>
</ol>
<p>
For all comparisons, we considered SUTI, bacteriuria/unspecified UTI, or combinations of these outcomes depending on availability, as well as other outcomes critical to weighing the risks and benefits of different catheterization approaches. The evidence for this question consists of 6 systematic reviews,37,104-108 16 RCTs,62,63,109-122 and 18 observational studies.54,73,81,84,123-136 The findings of the evidence review and the grades for all important outcomes are shown in Evidence Review Table 2A
</p>


<h6><em>
  Q2A.1. External versus indwelling urethral</em></h6>
<p>
Low-quality evidence suggested a benefit of using external catheters over indwelling urethral catheters in male patients who require a urinary collection device but do not have an indication for an indwelling catheter such as urinary retention or bladder outlet obstruction.81,109,123 This was based on a decreased risk of a composite outcome of SUTI, bacteriuria, or death as well as increased patient satisfaction with condom catheters. Differences were most pronounced in men without dementia. Statistically significant differences were not found or reported for the individual CAUTI outcomes or death. Our search did not reveal data on differences in local complications such as skin maceration or phimosis.
</p>
<h6><em>
  Q2A.2. Intermittent versus indwelling urethral</em></h6>
<p>
Low-quality evidence suggested a benefit of using intermittent catheterization over indwelling urethral catheters in selected populations.84,104-106,110-114,124-126,135,136 This was based on a decreased risk of SUTI and bacteriuria/unspecified UTI but an increased risk of urinary retention in postoperative patients with intermittent catheterization. In one study, urinary retention and bladder distension were avoided by performing catheterization at regular intervals (every 6-8 hrs) until return of voiding. Studies of patients with neurogenic bladder most consistently found a decreased risk of CAUTI with intermittent catheterization. Studies in operative patients whose catheters were removed within 24 hrs of surgery found no differences in bacteriuria with intermittent vs. indwelling catheterization, while studies where catheters were left in for longer durations had mixed results. Our search did not reveal data on differences in patient satisfaction.
</p>
<h6><em>
  Q2A.3. Intermittent versus suprapubic</em></h6>
<p>Very low-quality evidence suggested a benefit of intermittent over suprapubic catheterization in selected populations115,116,134-136 based on increased patient acceptability and decreased risk of urinary complications (bladder calculi, vesicoureteral reflux, and upper tract abnormalities). Although we found a decreased risk of bacteriuria/unspecified UTI with suprapubic catheterization, there were no differences in SUTI. The populations studied included women undergoing urogynecologic surgery and spinal cord injury patients. 
</p>
<h6><em>
  Q2A.4. Suprapubic versus indwelling urethral</em></h6>
<p>
Low-quality evidence suggested a benefit of suprapubic catheters over indwelling urethral catheters in selected populations.37,62,104,107,108,128-133,135,136 This was based on a decreased risk of bacteriuria/unspecified UTI, recatheterization, and urethral stricture, and increased patient comfort and satisfaction. However, there were no differences in SUTI and an increased risk of longer duration of catheterization with suprapubic catheters. Studies involved primarily postoperative and spinal cord injury patients. Our search did not reveal data on differences in complications related to catheter insertion or the catheter site.
</p>
<h6><em>
  Q2A.5. Clean intermittent versus sterile intermittent</em></h6>
<p>
Moderate-quality evidence suggested no benefit of using sterile over clean technique for intermittent catheterization.63,73,105,117-122 No differences were found in the risk of SUTI or bacteriuria/unspecified UTI. Study populations included nursing home residents and adults and children with neurogenic bladder/spinal cord injury. 
</p>

<div class="margin">
<div class="module rounders">
<div class="inner">
<div class="t"></div>

<h3>Evidence Review Table 2A.  What are the risks and benefits associated with different approaches to catheterization?</h3>

<div class="subColumns">
<div class="subc">
<p>2A.1. Consider using external catheters as an alternative to indwelling urethral catheters in cooperative male patients without urinary retention or bladder outlet obstruction. (Category II)
</p>
<p>
2A.2. Intermittent catheterization is preferable to indwelling urethral or suprapubic catheters in patients with bladder emptying dysfunction. (Category II) 
</p>
<p>
2A.3. If intermittent catheterization is used, perform it at regular intervals to prevent bladder overdistension. (Category IB)
</p>
<p>
2A.4. For operative patients who have an indication for an indwelling catheter, remove the catheter as soon as possible postoperatively, preferably within 24 hours, unless there are appropriate indications for continued use. (Category IB)*
</p>
<p>
2A.5. Further research is needed on the risks and benefits of suprapubic catheters as an alternative to indwelling urethral catheters in selected patients requiring short- or long-term catheterization, particularly with respect to complications related to catheter insertion or the catheter site. (No recommendation/unresolved issue)
</p>
<p>
2A.6. In the non-acute care setting, clean (i.e., non-sterile) technique for intermittent catheterization is an acceptable and more practical alternative to sterile technique for patients requiring chronic intermittent catheterization. (Category IA)
</p>
</div>
</div>
</div>

<div class="b">
<div></div>
</div>
</div>
<p>* More data are available under Question 2C</p>
</div>


<p class="topOPage"><a href="008_evidenceReview.html#">Top of Page</a></p> 
 <a name="2b" id="2b"></a>
 
<h4>Q2B. What are the risks and benefits associated with different catheters or collecting systems?</h4>
<p>
The available data examined the following comparisons between different types of catheters and drainage systems:
</p>
<ol>
  <li> 	Antimicrobial/antiseptic catheters vs. standard catheters
    <ol>
      <li type="a">Silver-coated catheters vs. standard catheters        </li>
      <li type="a">Nitrofurazone-impregnated catheters vs. standard catheters </li>
    </ol>
  </li>
  <li>	Hydrophilic catheters vs. standard catheters    </li>
  <li>	Closed vs. open drainage systems    </li>
  <li>	Complex vs. simple drainage systems    </li>
  <li>	Preconnected/sealed junction catheters vs. standard catheters    </li>
  <li>	Catheter valves vs. catheter bags </li>
</ol>
<p>
For all comparisons, we considered CAUTI outcomes as well as other outcomes critical to weighing the risks and benefits of different types of catheters or collecting systems. The evidence for this question consists of 5 systematic reviews,37,137-140 17 RCTs,64,143-158 23 observational studies,82,86,89,97,159-163, 165-178 and 3 economic analyses.179180,181 The findings of the evidence review and the grades for all important outcomes are shown in Evidence Review Table 2B.

</p>
<h6><em>
  Q2B.1.a. Silver-coated catheters vs. standard catheters</em></h6>
<p>
Low-quality evidence suggested a benefit of silver-coated catheters over standard latex catheters.37,82,86,137-139,143,159-163, 165,166 This was based on a decreased risk of bacteriuria/unspecified UTI with silver-coated catheters and no evidence of increased urethral irritation or antimicrobial resistance in studies that reported data on microbiological outcomes. Differences were significant for silver alloy-coated catheters but not silver oxide-coated catheters. In a meta-analysis of randomized controlled trials (see Appendix), silver alloy-coated catheters reduced the risk of asymptomatic bacteriuria compared to standard latex catheters (control latex catheters were either uncoated or coated with hydrogel, Teflon®, or silicone), whereas there were no differences when compared to standard, all silicone catheters. The effect of silver alloy catheters compared to latex catheters was more pronounced when used in patients catheterized &lt;1 week. The results were robust to inclusion or exclusion of non peer-reviewed studies. Only one observational study found a decrease in SUTI with silver alloy-coated catheters.166 The setting was a burn referral center, where the control catheters were latex, and patients in the intervention group had new catheters placed on admission, whereas the control group did not. Recent observational studies in hospitalized patients found mixed results for bacteriuria/unspecified UTI. 
</p>
<h6><em>
  Q2B.1.b. Nitrofurazone-impregnated catheters vs. standard catheters</em></h6>
<p>
Low-quality evidence suggested a benefit of nitrofurazone-impregnated catheters in patients catheterized for short periods of time.137,138 This was based on a decreased risk of bacteriuria and no evidence of increased antimicrobial resistance in studies that reported microbiological outcomes. Differences were significant in a meta-analysis of three studies examining nitrofurazone-impregnated catheters (only one individual study significant) when duration of catheterization was &lt;1 week. No differences were seen when duration of catheterization was >1 week, although the meta-analysis was borderline significant. 
</p>
<h6><em>
  Q2B.2. Hydrophilic catheters vs. standard catheters</em></h6>
<p>
Very low-quality evidence suggested a benefit of hydrophilic catheters over standard non-hydrophilic catheters in specific populations undergoing clean intermittent catheterization.137,144-148,169 This was based on a decreased risk of SUTI, bacteriuria, hematuria, and pain during insertion, and increased patient satisfaction. Differences in CAUTI outcomes were limited to one study of spinal cord injury patients and one study of patients receiving intravesical immunochemoprophylaxis for bladder cancer, while multiple other studies found no significant differences. 
</p>
<h6><em>
  Q2B.3. Closed vs. open drainage systems</em></h6>
<p>
Very low-quality evidence suggested a benefit of using a closed rather than open urinary drainage system.89,171 This was based on a decreased risk of bacteriuria with a closed drainage system. One study also found a suggestion of a decreased risk of SUTI, bacteremia, and UTI-related mortality associated with closed drainage systems, but differences were not statistically significant. Sterile, continuously closed drainage systems became the standard of care based on an uncontrolled study published in 1966 demonstrating a dramatic reduction in the risk of infection in short-term catheterized patients with the use of a closed system.23 Recent data also include the finding that disconnection of the drainage system is a risk factor for bacteriuria (Q1B).
</p>
<h6><em>
  Q2B.4. Complex vs. simple drainage systems</em></h6>
<p>
Low-quality evidence suggested no benefit of complex closed urinary drainage systems over simple closed urinary drainage systems.150-152,154,172,176,177 Although there was a decreased risk of bacteriuria with the complex systems, differences were found only in studies published before 1990, and not in more recent studies. The complex drainage systems studied included various mechanisms for reducing bacterial entry, such as antiseptic-releasing cartridges at the drain port of the urine collection bag; see evidence table for systems evaluated. 
</p>
<h6><em>
  Q2B.5. Preconnected/sealed junction catheters vs. standard catheters</em></h6>
<p>
Low-quality evidence suggested a benefit of using preconnected catheters with junction seals over catheters with unsealed junctions to reduce the risk of disconnections.64,153,156,175 This was based on a decreased risk of SUTI and bacteriuria with preconnected sealed catheters. Studies that found differences had higher rates of CAUTI in the control group than studies that did not find an effect. 
</p>
<h6><em>
  Q2B.6. Catheter valves vs. drainage bags</em></h6>
<p>
Moderate-quality evidence suggested a benefit of catheter valves over drainage bags in selected patients with indwelling urinary catheters.140 Catheter valves led to greater patient satisfaction but no differences in bacteriuria/unspecified UTI or pain/bladder spasms. Details regarding the setting for recruitment and follow-up of the patients in the studies were unclear, and the majority of subjects were men. Our search did not reveal data on the effect of catheter valves on bladder function, bladder/urethral trauma, or catheter blockage.

</p>
<div class="margin">
<div class="module rounders">
<div class="inner">
<div class="t"></div>

<h3>Evidence Review Table 2B.  What are the risks and benefits associated with different catheters or collecting systems?</h3>

<div class="subColumns">
<div class="subc">
<p>2B.1. If the CAUTI rate is not decreasing after implementing a comprehensive strategy to reduce rates of CAUTI, consider using antimicrobial/antiseptic-impregnated catheters. The comprehensive strategy should include, at a minimum, the high priority recommendations for urinary catheter use, aseptic insertion, and maintenance (see Section III. Implementation and Audit). (Category IB)
</p>
<p>
2B.1.a. Further research is needed on the effect of antimicrobial/antiseptic-impregnated catheters in reducing the risk of symptomatic UTI, their inclusion among the primary interventions, and the patient populations most likely to benefit from these catheters. (No recommendation/unresolved issue)
</p>
<p>
2B.2. Hydrophilic catheters might be preferable to standard catheters for patients requiring intermittent catheterization. (Category II) 
</p>
<p>
2B.3. Following aseptic insertion of the urinary catheter, maintain a closed drainage system. (Category IB)
</p>
<p>
2B.4. Complex urinary drainage systems (utilizing mechanisms for reducing bacterial entry such as antiseptic-release cartridges in the drain port) are not necessary for routine use. (Category II)
</p>
<p>
2B.5. Urinary catheter systems with preconnected, sealed catheter-tubing junctions are suggested for use. (Category II) 
</p>
<p>
2B.6. Further research is needed to clarify the benefit of catheter valves in reducing the risk of CAUTI and other urinary complications. (No recommendation/unresolved issue)
</p>
</div>
</div>
</div>

<div class="b">
<div></div>
</div>
</div>
</div>


<p class="topOPage"><a href="008_evidenceReview.html#">Top of Page</a></p> 
 <a name="2c" id="2c"></a>
 
<h4>Q2C. What are the risks and benefits associated with different catheter management techniques?</h4>
<p>
The available data examined the following catheter management techniques:
</p>
<ol>
  <li>
  Antimicrobial prophylaxis</li>
  <li>Urinary antiseptics (i.e., methanamine)    </li>
  <li> Bladder irrigation    </li>
  <li> Antiseptic instillation in the drainage bag</li>
  <li> Periurethral care</li>
  <li> Routine catheter or bag change    </li>
  <li> Catheter lubricants    </li>
  <li> Securing devices    </li>
  <li>Bacterial interference    </li>
  <li>Catheter cleansing    </li>
  <li> Catheter removal strategies (clamping vs. free drainage prior to removal, postoperative duration of catheterization)    </li>
  <li> Assessment of urine volumes </li>
</ol>
<p>
For all comparisons, we considered CAUTI outcomes as well as other outcomes critical to weighing the risks and benefits of different catheter management techniques. The evidence for this question consists of 6 systematic reviews,37,105,106,182-184 56 RCTs,60,61,65-69,143,158,158,185-231 34 observational studies,83,85,88,90,96,102,133,167,178,232-258 and 1 economic analysis.180 The findings of the evidence review and the grades for all important outcomes are shown in Evidence Review Table 2C.
</p>
<h6><em>
  
  Q2C.1. Antimicrobial prophylaxis</em></h6>
<p>
Low-quality evidence suggested no benefit of antimicrobial prophylaxis in patients undergoing short-term catheterization.37,60,61,83,85,133,158,178,182,185,186,189-191,232-234 This was based on heterogeneous results for SUTI and bacteriuria/unspecified UTI and no adverse events related to antimicrobials. Lack of consistency in specific factors, such as patient population, antimicrobial agents, timing of administration, and duration of follow-up, did not allow for a summary of evidence of the effect of antimicrobial prophylaxis on CAUTI in patients undergoing short term catheterization. Only two studies evaluated adverse events related to antimicrobials. Our search did not reveal data on antimicrobial resistance or Clostridium difficile infection. 
</p>
<p>
Low-quality evidence suggested no benefit of antimicrobial prophylaxis in patients undergoing long-term catheterization (indwelling and clean intermittent catheterization).106,183,192,194,235,238 This was based on a decreased risk of bacteriuria, heterogeneous results for SUTI, and no differences reported for catheter encrustation or adverse events, although data were sparse. One systematic review suggested an increase in antimicrobial resistance with antimicrobial use.
</p>
<h6><em>
  Q2C.2. Urinary antiseptics</em></h6>
<p>
Low-quality evidence suggested a benefit of methenamine for short-term catheterized patients.196,197 This was based on a reduced risk of SUTI and bacteriuria and no differences in adverse events. Evidence was limited to two studies of patients following gynecological surgery in Norway and Sweden.
</p>
<p>
Very low-quality evidence suggested a benefit of methanamine for long-term catheterized patients.106,236-239 This was based on a reduced risk of encrustation but no differences in risk of SUTI or bacteriuria. Data on encrustation was limited to one study. Studies involved primarily elderly and spinal cord injury patients with chronic indwelling catheters 
</p>
<h6><em>
  Q2C.3. Bladder irrigation</em></h6>
<p>
Low-quality evidence suggested no benefit of bladder irrigation in patients with indwelling or intermittent catheters.66,69,199-206,240-242 This was based on no differences in SUTI and heterogeneous findings for bacteriuria.
</p>
<h6><em>
  Q2C.4. Antiseptic instillation in the drainage bag</em></h6>
<p>
Low-quality evidence suggested no benefit of antiseptic instillation in urinary drainage bags.90,207-211,243-245 This was based on no differences in SUTI and heterogeneous results for bacteriuria.
</p>
<h6><em>
  Q2C.5. Periurethral care</em></h6>
<p>
Low-quality evidence suggested no benefit of antiseptic meatal cleaning regimens before or during catheterization to prevent CAUTI.65,67,68,88,158,212-216,246,247 This was based on no difference in the risk of bacteriuria in patients receiving periurethral care regimens compared to those not receiving them. One study found a higher risk of bacteriuria with cleaning of the urethral meatus-catheter junction (either twice daily application of povidine-iodine or once daily cleaning with a non-antiseptic solution of green soap and water) in a subgroup of women with positive meatal cultures and in patients not receiving antimicrobials. Periurethral cleaning with chlorhexidine before catheter insertion did not have an effect in two studies.
</p>
<h6><em>
  Q2C.6. Routine catheter or bag change</em></h6>
<p>
Low-quality evidence suggested no benefit of routine catheter or drainage bag changes to prevent CAUTI.102,217-219,248,249 This was based on no difference or an increased risk of SUTI and no difference in bacteriuria with routine compared to as-needed changes or with more frequent changing intervals. One study in nursing home residents found no differences in SUTI with routine monthly catheter changes compared to changing only for obstruction or infection, but the study was underpowered to detect a difference. Another study in home care patients found an increased risk of SUTI when catheters were changed more frequently than monthly.
</p>
<h6><em>
  Q2C.7. Catheter lubricants</em></h6>
<p>
Very low-quality evidence suggested a benefit of using lubricants for catheter insertion.167,220-223,250-254 This was based on a decreased risk of SUTI and bacteriuria with the use of a pre-lubricated catheter compared to a catheter lubricated by the patient and a decreased risk of bacteriuria with use of a lubricant versus no lubricant. Studies were heterogeneous both in the interventions and outcomes studied. Several studies comparing antiseptic lubricants to non-antiseptic lubricants found no significant differences.
</p>
<h6><em>
  Q2C.8. Securing devices</em></h6>
<p>
Low-quality evidence suggested no benefit of using catheter securing devices to prevent CAUTI.224 This was based on no significant difference in the risk of SUTI or meatal erosion. The only study in this category looked at one particular product.
</p>
<h6><em>
  Q2C.9. Bacterial interference</em></h6>
<p>
Moderate-quality evidence suggested a benefit of using bacterial interference in catheterized patients.225 In the one study evaluating this intervention, urinary colonization with a non-pathogenic Escherichia coli was associated with a decreased risk of SUTI in adults with spinal cord injury and a history of frequent CAUTI.
</p>
<h6><em>
  Q2C.10. Catheter cleansing</em></h6>
<p>
Very low-quality evidence suggested a benefit of wet versus dry storage procedures for catheters used in clean intermittent catheterization.255 This was based on a decreased risk of SUTI with a wet storage procedure in one study of spinal cord injury patients undergoing clean intermittent catheterization compared to a dry storage procedure where the catheter was left to air dry after washing. In the wet procedure, the catheter was stored in a dilute povidone-iodine solution after washing with soap and water.
</p>
<h6><em>
  Q2C.11. Catheter removal strategies</em></h6>
<p>
a. Clamping vs. free drainage prior to removal
</p>
<p>
Low-quality evidence suggested no benefit of clamping versus free drainage before catheter removal.37,184 This was based on no difference in risk of bacteriuria, urinary retention, or recatheterization between the two strategies. One study comparing a clamp and release strategy to free drainage over 72 hours found a greater risk of bacteriuria in the clamping group.
</p>
<p>

b. Postoperative duration of catheterization
</p>
<p>
Moderate-quality evidence suggested a benefit of shorter versus longer postoperative durations of catheterization.37,184,227,228 This was based on a decreased risk of bacteriuria/unspecified UTI, decreased time to ambulation and length of stay, no differences in urinary retention and SUTI, and increased risk of recatheterization. Significant decreases in bacteriuria/unspecified UTI were found specifically for comparisons of 1 day versus 3 or 5 days of postoperative catheterization. Recatheterization risk was greater in only one study comparing immediate removal to removal 6 or 12 hours after hysterectomy.
</p>
<h6><em> 
  Q2C.12. Assessment of urine volumes</em></h6>
<p>
Low-quality evidence suggested a benefit of using portable ultrasound to assess urine volume in patients undergoing intermittent catheterization.229,230 This was based on fewer catheterizations but no reported differences in risk of unspecified UTI. Patients studied were adults with neurogenic bladder in inpatient rehabilitation centers. Our search did not reveal data on the use of ultrasound in catheterized patients in other settings.

</p>

<div class="margin">
<div class="module rounders">
<div class="inner">
<div class="t"></div>

<h3>Evidence Review Table 2C.  What are the risks and benefits associated with different catheter management techniques?</h3>

<div class="subColumns">
<div class="subc">
<p>2C.1. Unless clinical indications exist (e.g., in patients with bacteriuria upon catheter removal post urologic surgery), do not use systemic antimicrobials routinely as prophylaxis for UTI in patients requiring either short or long-term catheterization. (Category IB)
</p>
<p>
2C.2.a. Further research is needed on the use of urinary antiseptics (e.g., methanamine) to prevent UTI in patients requiring short-term catheterization. (No recommendation/unresolved issue)
</p>
<p>2C.2.b. Further research is needed on the use of methanamine to prevent encrustation in patients requiring chronic indwelling catheters who are at high risk for obstruction. (No recommendation/unresolved issue) 
</p>
<p>
2C.3.a. Unless obstruction is anticipated (e.g., as might occur with bleeding after prostatic or bladder surgery), bladder irrigation is not recommended. (Category II)
</p>
<p>2C.3.b. Routine irrigation of the bladder with antimicrobials is not recommended. (Category II)
</p>
<p>
2C.4. Routine instillation of antiseptic or antimicrobial solutions into urinary drainage bags is not recommended. (Category II)
</p>
<p>
2C.5.a. Do not clean the periurethral area with antiseptics to prevent CAUTI while the catheter is in place. Routine hygiene (e.g., cleansing of the meatal surface during daily bathing) is appropriate. (Category IB)
</p>
<p>2C.5.b. Further research is needed on the use of antiseptic solutions vs. sterile water or saline for periurethral cleaning prior to catheter insertion. (No recommendation/unresolved issue)
</p>
<p>
2C.6. Changing indwelling catheters or drainage bags at routine, fixed intervals is not recommended.  Rather, catheters and drainage bags should be changed based on clinical indications such as infection, obstruction, or when the closed system is compromised. (Category II)
</p>
<p>
2C.7.a. Use a sterile, single-use packet of lubricant jelly for catheter insertion. (Category IB)
</p>
<p>2C.7.b. Routine use of antiseptic lubricants is not necessary. (Category II)

</p>
<p>2C.8. Further research is needed on the use of bacterial interference to prevent UTI in patients requiring chronic urinary catheterization. (No recommendation/unresolved issue)
</p>
<p>
2C.9. Further research is needed on optimal cleaning and storage methods for catheters used for clean intermittent catheterization. (No recommendation/unresolved issue)
</p>
<p>
2C.10.a. Clamping indwelling catheters prior to removal is not necessary. (Category II)
</p>
<p>2C.10.b. Insert catheters only for appropriate indications, and leave in place only as long as needed. (Category IB)</p>
<p>
2C.10.c. For operative patients who have an indication for an indwelling catheter, remove the catheter as soon as possible postoperatively, preferably within 24 hours, unless there are appropriate indications for continued use. (Category IB)
</p>
<p>
2C.11.a. Consider using a portable ultrasound device to assess urine volume in patients undergoing intermittent catheterization to assess urine volume and reduce unnecessary catheter insertions. (Category II)
</p>
<p>2C.11.b. Further research is needed on the use of a portable ultrasound device to evaluate for obstruction in patients with indwelling catheters and low urine output. (No recommendation/unresolved issue)
</p>
</div>
</div>
</div>

<div class="b">
<div></div>
</div>
</div>
</div>


<p class="topOPage"><a href="008_evidenceReview.html#">Top of Page</a></p> 
 <a name="2d" id="2d"></a>
 
<h4>Q2D. What are the risks and benefits associated with different systems interventions?</h4>
<p>
The available data examined the following systems interventions:</p>
<ol>
  <li>
  Infection control/quality improvement programs (multifaceted)</li>
  <li> Catheter reminders    </li>
  <li> Bacteriologic monitoring    </li>
  <li> Hand hygiene    </li>
  <li> Patient placement    </li>
  <li>Catheter team versus self-catheterization    </li>
  <li> Feedback    </li>
  <li> Nurse-directed catheter removal </li>
</ol>
<p>
We considered CAUTI outcomes, duration of catheterization, recatheterization, and transmission of pathogens when weighing the risks and benefits of different systems interventions. The evidence for this question consists of 1 RCT259 and 19 observational studies.3,25,260-276 The findings of the evidence review and the grades for all important outcomes are shown in Evidence Review Table 2D. 
</p>
<h6><em>
  Q2D.1. Multifaceted infection control/quality improvement programs</em></h6>
<p>
Low-quality evidence suggested a benefit of multifaceted infection control/quality improvement programs to reduce the risk of CAUTI.3,260-267 This was based on a decreased risk of SUTI, bacteriuria/unspecified UTI, and duration of catheter use with implementation of such programs. Studies evaluated various multifaceted interventions. The studies with significant findings included: 1) education and performance feedback regarding compliance with catheter care, emphasizing hand hygiene, and maintaining unobstructed urine flow; 2) computerized alerts to physicians, nurse-driven protocols to remove catheters, and use of handheld bladder scanners to assess for urinary retention; 3) guidelines and education focusing on perioperative catheter management; and 4) a multifaceted infection control program including guidelines for catheter insertion and maintenance. A program using a checklist and algorithm for appropriate catheter use also suggested a decrease in unspecified UTI and catheter duration, but statistical differences were not reported.
</p>
<h6><em>
  Q2D.2. Reminders</em></h6>
<p>
Very low-quality evidence suggested a benefit of using urinary catheter reminders to prevent CAUTI.268-270 This was based on a decreased risk of bacteriuria and duration of catheterization and no differences in recatheterization or SUTI when reminders were used. Reminders to physicians included both computerized and non-computerized alerts about the presence of urinary catheters and the need to remove unnecessary catheters.
</p>
<h6><em>	
  Q2D.3. Bacteriologic monitoring</em></h6>
<p>
Very low-quality evidence suggested no benefit of bacteriologic monitoring to prevent CAUTI.25,271 Although one study found a decreased risk of bacteriuria during a period of bacteriologic monitoring and feedback, only 2% of SUTI episodes were considered potentially preventable with the use of bacteriologic monitoring. 
</p>
<h6><em>
  Q2D.4. Hand hygiene</em></h6>
<p>
Very low-quality evidence suggested a benefit of using alcohol hand sanitizer in reducing CAUTI. This was based on one study in a rehabilitation facility that found a decrease in unspecified UTI, although no statistical differences were reported.272 A separate multifaceted study that included education and performance feedback on compliance with catheter care and hand hygiene showed a decrease in risk of SUTI.265
</p>
<h6><em>
  Q2D.5. Patient placement</em></h6>
<p>
Very low-quality evidence suggested a benefit of spatially separating patients to prevent transmission of urinary pathogens.273 This was based on a decreased risk of transmission of urinary bacterial pathogens in nursing home residents in separate rooms compared to residents in the same rooms.
</p>
<h6><em>
  Q2D.6. Catheter team versus self-catheterization</em></h6>
<p>
Very low-quality evidence suggested no benefit of a catheter team to prevent CAUTI among patients requiring intermittent catheterization.274 This was based on one study showing no difference in unspecified UTI between use of a catheter care team and self-catheterization for intermittent catheterization in paraplegic patients.
</p>
<h6><em>
  Q2D.7. Feedback</em></h6>
<p>
Very low-quality evidence suggested a benefit of using nursing feedback to prevent CAUTI.275 This was based on a decreased risk of unspecified UTI during an intervention where nursing staff were provided with regular reports of unit-specific rates of CAUTI. 
</p>
<h6><em>
  Q2D.8. Nurse-directed catheter removal</em></h6>
<p>
Very low-quality evidence suggested a benefit of a nurse-directed catheter removal program to prevent CAUTI.276 This was based on a decreased risk of unspecified UTI during an intervention where criteria were developed that allowed a registered nurse to remove a catheter without a physician's order when no longer medically necessary. Of the three intensive care units where the intervention was implemented, differences were significant only in the coronary intensive care unit.

</p>


<div class="margin">
<div class="module rounders">
<div class="inner">
<div class="t"></div>

<h3>Evidence Review Table 2D.  What are the risks and benefits associated with different systems interventions?</h3>

<div class="subColumns">
<div class="subc">
<p>2D.1.a. Ensure that healthcare personnel and others who take care of catheters are given periodic in-service training stressing the correct techniques and procedures for urinary catheter insertion, maintenance, and removal. (Category IB)
</p>
<p>2D.1.b. Implement quality improvement (QI) programs or strategies to enhance appropriate use of indwelling catheters and to reduce the risk of CAUTI based on a facility risk assessment. (Category IB) 
	</p>
<p>Examples of programs that have been demonstrated to be effective include:</p>
<p>
1.	A system of alerts or reminders to identify all patients with urinary catheters and assess the need for continued catheterization 
2.	Guidelines and protocols for nurse-directed removal of unnecessary urinary catheters 
3.	Education and performance feedback regarding appropriate use, hand hygiene, and catheter care
4.	Guidelines and algorithms for appropriate peri-operative catheter management, such as:
a.	Procedure-specific guidelines for catheter placement and postoperative catheter removal
b.	Protocols for management of postoperative urinary retention, such as nurse-directed use of intermittent catheterization and use of ultrasound bladder scanners
</p>
<p>
2D.2. Routine screening of catheterized patients for asymptomatic bacteriuria is not recommended. (Category II)
</p>
<p>
2D.3. Perform hand hygiene immediately before and after insertion or any manipulation of the catheter site or device. (Category IB) 
</p>
<p>
2D.5. Maintain unobstructed urine flow. (Category IB)
</p>
<p>
2D.6. Further research is needed on the benefit of spatial separation of patients with urinary catheters to prevent transmission of pathogens colonizing urinary drainage systems. (No recommendation/unresolved issue)
</p>
<p>
2D.7. When performing surveillance for CAUTI, consider providing regular (e.g., quarterly) feedback of unit-specific CAUTI rates to nursing staff and other appropriate clinical care staff. (Category II) 

</p>
</div>
</div>
</div>

<div class="b">
<div></div>
</div>
</div>
</div>

<p class="topOPage"><a href="008_evidenceReview.html#">Top of Page</a></p> 
 <a name="3" id="3"></a>
 
<h3>Q3: What are the best practices for preventing UTI associated with obstructed urinary catheters?</h3>
<p>
The available data examined the following practices:
</p>
<ol>
  <li>
  Methods to prevent/reduce encrustations or blockage</li>
  <li> Catheter materials preventing blockage </li>
</ol>
<p>
For this question, available relevant outcomes included blockage/encrustation. We did not find data on the outcomes of CAUTI. The evidence for this question consists of 1 systematic review,277 2 RCTs,278,279 and 2 observational studies.280,281 The findings of the evidence review and the grades for all important outcomes are shown in Evidence Review Table 3. 
</p>
<h6><em>
  Q3.1. Methods to prevent/reduce encrustations or blockage</em></h6>
<p>
Low-quality evidence suggested a benefit of acidifying solutions or oral acetohydroxamic acid in preventing or reducing catheter encrustations and blockage in long-term catheterized patients.277,278,280,281 No differences were seen with daily catheter irrigation with normal saline.
</p>
<h6><em>
  Q3.2. Catheter materials preventing blockage</em></h6>
<p>
Low-quality evidence suggested a benefit of silicone over latex or Teflon-coated catheters in prevention or reducing catheter encrustations in long-term catheterized patients who were prone to blockage. No differences were seen with different materials in patients considered &quot;non-blockers.&quot;279 

</p>


<div class="margin">
<div class="module rounders">
<div class="inner">
<div class="t"></div>

<h3>Evidence Review Table 3.  What are the best practices for preventing UTI associated with obstructed urinary catheters?</h3>

<div class="subColumns">
<div class="subc">
<p>

3.1.a. Further research is needed on the benefit of irrigating the catheter with acidifying solutions or use of oral urease inhibitors in long-term catheterized patients who have frequent catheter obstruction. (No recommendation/unresolved issue)
</p>
<p>
3.2.a. Silicone might be preferable to other materials to reduce the risk of encrustation in long-term catheterized patients who have frequent obstruction. (Category II)
</p>
</div>
</div>
</div>

<div class="b">
<div></div>
</div>
</div>
</div>



                       <p class="topOPage"><a href="008_evidenceReview.html#">Top of Page</a></p> 

<div class="module rounders grey multiPage-horiz" id="tableOfContent">
<div class="inner">
<div class="t"></div>

<div class="hd">
<h4><span><a href="007_methods.html">Previous Page</a></span>
<span class="nextLink"><a href="008_evidenceReview.html">Next Page</a></span></h4>
</div>

<div class="bd"><span><a href="002_cauti_toc.html">Table of Contents</a></span></div>
</div>

<div class="b">
<div></div>
</div>
</div>                    
                       
					<!-- InstanceEndEditable -->
					<div id="linkPolicy">&nbsp;</div>
				<!-- End .main-inner --></div>
				
			<!-- End #content-main--></div>
		<!-- End #content-inner --></div>
		
		<!-- ########## RIGHT COLUMN STARTS HERE ########## -->
		<div id="content-secondary">
			<div class="pageOptions">
				<div class="pageOptions-inner">
					<!-- If you're seeing this, the text-sizer include is depricated and the server-side-include reference should be removed from all pages -->
					<ul id="services" class="services">
						<li class="print"><a href="javascript:window.print();" title="Print page.">Print page</a></li>
					</ul>
					<!-- InstanceBeginEditable name="local-options" -->
					 
                        <ul>
                         <h5>Download page:</h5>
                        <li class="pdf"><a href="https://www.cdc.gov/hicpac/pdf/CAUTI/Pages34_48CAUTIguideline2009final.pdf">PDF [255 KB]</a></li>
					</ul>
					<!-- InstanceEndEditable -->
					<!-- InstanceBeginEditable name="languages" -->
					 
				<!-- InstanceEndEditable --></div>
			</div>
			
			
			
			<!-- InstanceBeginEditable name="gov-delivery" -->
			
			<!-- InstanceEndEditable -->
			
			<!-- InstanceBeginEditable name="contact-info" -->
			<div id="contact-info">
	<h5>Contact Us:</h5>
	<ul class="noBullet">
		<li class="mail">Centers for Disease Control and Prevention<br />
		1600 Clifton Rd<br />
		Atlanta, GA 30333</li>
		<li class="phone">800-CDC-INFO<br />
		(800-232-4636)<br />
		TTY: (888) 232-6348</li>
		<li><a href="../../cdc-info/requestform.html">Contact CDC&ndash;INFO</a></li>
	</ul>
</div>
			<!-- InstanceEndEditable -->
			
		<!-- End #content-secondary --></div>
		
	<!-- End #content --></div>
	
	<div class="preFoot">
		<div id="plugin-legend">
			<h3>File Formats Help:</h3>
			<ul>
				<li class="plugin-pdf"><a href="../../Other/plugins/index.html#pdf"><img src="../../TemplatePackage/images/icon_pdf.gif" alt="Adobe PDF file" /></a></li>
				<li class="plugin-word"><a href="../../Other/plugins/index.html#doc"><img src="../../TemplatePackage/images/icon_word.gif" alt="Microsoft Word file" /></a></li>
				<li class="plugin-excel"><a href="../../Other/plugins/index.html#xls"><img src="../../TemplatePackage/images/icon_excel.gif" alt="Microsoft Excel file" /></a></li>
				<li class="plugin-ppt"><a href="../../Other/plugins/index.html#ppt"><img src="../../TemplatePackage/images/icon_ppt.gif" alt="Microsoft PowerPoint file" /></a></li>
				<li class="plugin-wmv"><a href="../../Other/plugins/index.html#wmv"><img src="../../TemplatePackage/images/icon_wmv.gif" alt="Audio/Video file" /></a></li>
				<li class="plugin-zip"><a href="../../Other/plugins/index.html#zip"><img src="../../TemplatePackage/images/icon_zip.gif" alt="Zip Archive file" /></a></li>
				<li class="plugin-real"><a href="../../Other/plugins/index.html#ram"><img src="../../TemplatePackage/images/icon_real.gif" alt="RealPlayer file" /></a></li>
				<li class="plugin-qt"><a href="../../Other/plugins/index.html#qt"><img src="../../TemplatePackage/images/icon_qt.gif" alt="Apple Quicktime file" /></a></li>
			</ul>
			<p><a href="../../Other/plugins/index.html"><span class="tp-label">How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?</span>&nbsp;<img src="../../TemplatePackage/images/btn_dblArrows.gif" alt="double arrows." /></a></p>
		</div>
		
		<div class="pageOptions-horizontal">
			<ul class="services">
				<li class="print"><a href="javascript:window.print();">Print</a></li>

				<!-- InstanceBeginEditable name="local-options-horizontal" -->
				
				<!-- InstanceEndEditable -->
			</ul>
		</div>
		<div id="datestamp"><!-- InstanceBeginEditable name="date-stamp" -->
			<ul>
				<li class="last-reviewed">Page last reviewed: <span>December 29, 2009</span></li>
				<li class="last-updated">Page last updated: <span>December 29, 2009</span></li>
				<li class="content-source">Content source: <a href="../../index.html">Centers for Disease Control and Prevention</a></li>
                 <li class="content-source"><a href="https://www.cdc.gov/ncpdcid/">National Center for Preparedness, Detection, and Control of Infectious Diseases (NCPDCID)</a></li>
        <li class="content-source"><a href="https://www.cdc.gov/ncidod/dhqp/index.html">Division of Healthcare Quality Promotion (DHQP) </a></li>
			</ul>
		<!-- InstanceEndEditable --></div>
	</div>
	
	<div id="siteinfo">
	<div id="siteinfo-nav">
		<ul class="menu">
			<li><a href="../../index.html">Home</a></li>
			<li><a href="../../az/a.html">A-Z Index</a></li>
			<li><a href="../../Other/policies.html">Policies</a></li>
			<li><a href="../../Other/about_cdcgov.html">Using this Site</a></li>
			<li><a href="../../Other/link.html">Link to Us</a></li>
			<li class="last-child"><a href="../../contact.1.html">Contact CDC</a></li>
		</ul>
	</div>
	<div id="siteinfo-credits">
		<div id="siteinfo-logos"><a href="https://www.usa.gov//"><img id="logo_usagov" src="../../TemplatePackage/images/logo_usagov.gif" alt="USA.gov: The U.S. Government's Official Web Portal" width="188" height="55" border="0" /></a><a href="https://www.hhs.gov/"><img id="logo_dhhs" src="../../TemplatePackage/images/logo_dhhs.gif" alt="Department of Health and Human Services" width="61" height="55" border="0" /></a></div>
		<address>Centers for Disease Control and Prevention &nbsp; 1600 Clifton Road Atlanta, GA 30329-4027, USA<br />
		800-CDC-INFO (800-232-4636)	TTY: (888) 232-6348 - <a href="https://wwwn.cdc.gov/dcs/RequestForm.aspx">Contact CDC&ndash;INFO</a></address>
	</div>
</div>

<!--include virtual="/TemplatePackage/3.0/includes/interstitialModal.html" -->
	
	<div id="AZlist-container"><a name="az"></a>
	<span>A-Z Index</span>
	<ol class="AZlist">
		<li><a href="../../az/a.html">A</a></li>
		<li><a href="../../az/b.html">B</a></li>
		<li><a href="../../az/c.html">C</a></li>
		<li><a href="../../az/d.html">D</a></li>
		<li><a href="../../az/e.html">E</a></li>
		<li><a href="../../az/f.html">F</a></li>
		<li><a href="../../az/g.html">G</a></li>
		<li><a href="../../az/h.html">H</a></li>
		<li><a href="../../az/i.html">I</a></li>
		<li><a href="../../az/j.html">J</a></li>
		<li><a href="../../az/k.html">K</a></li>
		<li><a href="../../az/l.html">L</a></li>
		<li><a href="../../az/m.html">M</a></li>
		<li><a href="../../az/n.html">N</a></li>
		<li><a href="../../az/o.html">O</a></li>
		<li><a href="../../az/p.html">P</a></li>
		<li><a href="../../az/q.html">Q</a></li>
		<li><a href="../../az/r.html">R</a></li>
		<li><a href="../../az/s.html">S</a></li>
		<li><a href="../../az/t.html">T</a></li>
		<li><a href="../../az/u.html">U</a></li>
		<li><a href="../../az/v.html">V</a></li>
		<li><a href="../../az/w.html">W</a></li>
		<li><a href="../../az/x.html">X</a></li>
		<li><a href="../../az/y.html">Y</a></li>
		<li><a href="../../az/z.html">Z</a></li>
		<li><a href="../../az/0.html">#</a></li>
	</ol>
</div>


<!-- End #wrapper --></div>

<!-- xxxxxxxxxxxxxxxxxx METRICS code begins here xxxxxxxxxxxxxxxxxxxxxxxxxxx-->
<div id="metrics">

<!-- Begin Google DAP inclusion -->
<script type="text/javascript" id="_fed_an_ua_tag" src="../../JScript/metrics/google/Universal-Federated-Analytics-Min.js@agency=HHS&amp;subagency=CDC"></script>
<!-- End Google DAP inclusion -->

<!-- SiteCatalyst code version: H.21. -->
<script language="JavaScript" type="text/javascript" src="../../JScript/metrics/topic_levels.js"></script>
<script language="JavaScript" type="text/javascript" src="../../JScript/metrics/s_code_v21_cdcgov.js"></script>
<script language="JavaScript" type="text/javascript">

<!-- InstanceBeginEditable name="metrics" -->
s.pageName=document.title;
s.channel="HICPAC";

siteCatalyst.setLevel1("NCEZID"); 
siteCatalyst.setLevel2("DHQP"); 
siteCatalyst.setLevel3("Healthcare Infection Control Practices Advisory Committee"); 
<!-- InstanceEndEditable -->
s.prop2=window.location.href;
s.prop26=document.title;
s.prop30=document.title;
s.prop31=window.location.href;
s.prop46=window.location.href;
s.server=window.location.hostname;

// Update the level variables here.
updateVariables(s);

/************* DO NOT ALTER ANYTHING BELOW THIS LINE ! **************/
var s_code=s.t();if(s_code)document.write(s_code);//--></script>
<script language="JavaScript" type="text/javascript"><!--
if(navigator.appVersion.indexOf('MSIE')>=0)document.write(unescape('%3C')+'\!-'+'-');
//--></script><noscript><a href="http://www.omniture.com" title="Web Analytics"><img src="https://smtrics.cdc.gov/b/ss/cdcgov/1/H.21--NS/01/H.21--NS/0" height="1" width="1" border="0" alt="Web Analytics" /></a></noscript><!--/DO NOT REMOVE/-->
<!-- End SiteCatalyst code version: H.21. -->
<!-- Begin Template Package Custom Interactions -->
<script type="text/javascript" src="../../JScript/metrics/rd_custom_interactions.js"></script>
<!-- End Template Package Custom Interactions -->
<!-- Begin Template Package DigitalGov Search Support -->
<script type="text/javascript" src="../../JScript/rd_search.js"></script>
<!-- End Template Package DigitalGov Search Support -->
</div>
<!-- xxxxxxxxxxxxxxxxxx METRICS code ends here xxxxxxxxxxxxxxxxxxxxxxxxxxx-->



</body>
<!-- InstanceEnd --></html>
